Consensus Recommendations on JAK Inhibitor Use: A steering committee and task force was convened to develop recommendations for the use of Janus kinase (JAK) inhibitors in the treatment of immune-mediated inflammatory diseases (IMID). https://t.co/CKOfX6SE9V https://t.co/ZSUXOxzrqJ